Ashish Verma MD

Assistant Professor, Nephrology

650 Albany St | (617) 638-7339
Ashish Verma
Sections

Nephrology

Biography

Dr. Verma is a clinician-investigator interested in chronic kidney disease (CKD), cardiorenal syndrome, diabetic kidney disease(DKD), renal physiology, and electrolyte abnormalities. Dr. Verma's research projects include epidemiologic investigations utilizing large databases and translational and patient-oriented research projects. Ongoing studies include: predictors of CKD progression using CRIC cohort, predictors of mortality in CKD patients using NHANES, Physiology study examining the role of Kidney Function Reserve and renal plasma flow in phenotyping chronic kidney disease and the role of intravitreal VEGF inhibitors in causing nephrotoxicity.

Education

Medicine, MBBS, Stanley Medical School, 2012

Publications

Published on 11/1/2022

Liu J, Bankir L, Verma A, Waikar SS, Palsson R. Association of the Urine-to-Plasma Urea Ratio With CKD Progression. Am J Kidney Dis. 2022 Nov 01. PMID: 36356680.

Published on 10/11/2022

Verma A, Vaidya A, Subudhi S, Waikar SS. Aldosterone in chronic kidney disease and renal outcomes. Eur Heart J. 2022 Oct 11; 43(38):3781-3791. PMID: 36219773.

Published on 9/15/2022

Claudel SE, Waikar SS, Verma A. Severe hyponatremia due to surreptitious water intoxication in a hospitalized patient. CEN Case Rep. 2022 Sep 15. PMID: 36107392.

Published on 8/31/2022

Ilori TO, Liu J, Rodan AR, Verma A, Mills KT, He J, Winkler CA, Dupuis J, Anderson CAM, Waikar SS. Apolipoprotein L1 Genotypes and the Association of Urinary Potassium Excretion with CKD Progression. Clin J Am Soc Nephrol. 2022 Oct; 17(10):1477-1486. PMID: 36400568.

Published on 4/13/2022

Ujjawal A, Schreiber B, Verma A. Sodium-glucose cotransporter-2 inhibitors (SGLT2i) in kidney transplant recipients: what is the evidence? Ther Adv Endocrinol Metab. 2022; 13:20420188221090001. PMID: 35450095.

Published on 3/2/2022

Claudel SE, Schmidt IM, Verma A. A Call for Implementation Science: Achieving Equitable Access to SGLT2 Inhibitors. Kidney360. 2022 May 26; 3(5):942-944. PMID: 36128478.

Published on 1/18/2022

Albuquerque AM, Santolia CB, Verma A. Concerns about the interpretation of subgroup analysis. J Clin Invest. 2022 01 18; 132(2). PMID: 34855622.

Published on 1/13/2022

Subudhi S, Voutouri C, Hardin CC, Nikmaneshi MR, Patel AB, Verma A, Khandekar MJ, Dutta S, Stylianopoulos T, Jain RK, Munn LL. Strategies to minimize heterogeneity and optimize clinical trials in Acute Respiratory Distress Syndrome (ARDS): Insights from mathematical modelling. EBioMedicine. 2022 Jan; 75:103809. PMID: 35033853.

Published on 1/1/2022

Liu J, Tio MC, Verma A, Schmidt IM, Ilori TO, Knauf F, Mc Causland FR, Waikar SS. Determinants and Outcomes Associated With Urinary Calcium Excretion in Chronic Kidney Disease. J Clin Endocrinol Metab. 2022 01 01; 107(1):e281-e292. PMID: 34390334.

Published on 7/4/2021

Leung G, Verma A. Epidemiological Study of COVID-19 Fatalities and Vaccine Uptake: Insight From a Public Health Database in Ontario, Canada. Cureus. 2021 Jul; 13(7):e16160. PMID: 34367770.

View full list of 37 publications.